The first two exons of ESR1 were found to fuse with an N-terminal truncated CCDC170 fragment (ΔCCDC170) (Figure 4) [110]; the fusion gene was enriched in endocrine resistant luminal B breast cancers and its expression was driven by the ESR1 promoter [110]. Here, ESR1 is linked to breast carcinoma.